curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Quality of Life of Caregivers Supporting an Older Adult With Cancer

by palligoelme@gmail.com | Jul 15, 2026 | Clinical Trials

​ Conditions: Caregiver Quality of Life; Geriatric Oncology; Geriatric Medicine Interventions: Other: CarGOQol scale Sponsors: Assistance Publique – Hôpitaux de Paris Not yet recruiting Conditions: Caregiver Quality of Life; Geriatric Oncology; Geriatric...

Box Breathing Versus Foot Reflexology on Physiological and Psychological Stress Indicators in Emergency Physicians

by palligoelme@gmail.com | Jul 15, 2026 | Clinical Trials

​ Conditions: Stress Interventions: Other: Box Breathing; Other: Foot Reflexology Sponsors: Cairo University Not yet recruiting Conditions: Stress Interventions: Other: Box Breathing; Other: Foot Reflexology Sponsors: Cairo University Not yet...

Effect of Monosodium Glutamate on Microbiome-Derived Imidazole Propionate Production in Healthy Volunteers

by palligoelme@gmail.com | Jul 14, 2026 | Clinical Trials

​ Conditions: Healthy Adult Interventions: Dietary Supplement: L-histidine; Dietary Supplement: Monosodium glutamate (MSG); Dietary Supplement: Sodium chloride (NaCl) Sponsors: University of Chicago Not yet recruiting Conditions: Healthy Adult Interventions: Dietary...

Esketamine Versus Sufentanil for Sedation in Patients Undergoing ERCP

by palligoelme@gmail.com | Jul 14, 2026 | Clinical Trials

​ Conditions: Biliary Tract Diseases; Procedural Sedation and Analgesia Interventions: Drug: Esketamine; Drug: Sufentanil Sponsors: Ren Da Not yet recruiting Conditions: Biliary Tract Diseases; Procedural Sedation and Analgesia Interventions: Drug: Esketamine; Drug:...

The Efficacy and Safety of SGLT2Is on Kidney Function, Proteinuria, and Estimated Glomular Filteration Rate (eGFR) in Lupus Nephritis Population

by palligoelme@gmail.com | Jul 14, 2026 | Clinical Trials

​ Conditions: Lupus Nephritis (LN) Interventions: Drug: Empagliflozin (25 Mg Tab) along with standard medical therapy; Drug: Placebo and standard of care Sponsors: Ahmed Yehia Ismail Recruiting Conditions: Lupus Nephritis (LN) Interventions: Drug: Empagliflozin (25 Mg...
« Older Entries
Next Entries »

Recent Posts

  • Estimation of Control Before and After Treatment of a Depressive Episode With Serotonin Reuptake Inhibitors
  • A Phase II Clinical Trial of the Safety and Efficacy of SAL0120 in Patients With Chronic Kidney Disease (CKD)
  • The Effects of a Smartphone-Based Acceptance and Commitment Therapy Program on the Mental Health and Quality of Life of Caregivers Working in Long-Term Care Facilities
  • Web-Based Advance Care Planning for Patients With Advanced Cancer
  • Adequacy of Haemodiafiltration: Middle Molecules Clearance, Patients Reported Outcomes and Sodium Balance

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®